Back

Age at diagnosis determines coronary artery risk in familial hypercholesterolemia: a population-based study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Chronic coronary syndromes and comorbidities Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Emil Nielsen Holck

Aarhus University Hospital, Aarhus (Denmark)

4 More presentations in this session

Presentation thumbnail
Lymphangiogenic factors and all-cause and cause-specific mortality and impact of chronic kidney disease on them in patients with suspected or known coronary artery disease: The EXCEED-J Study
Doctor H. Wada (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Impact of chronic kidney disease on left ventricular and left atrial structure and function in STEMI patients treated with primary PCI: a comprehensive echocardiographic analysis
Doctor J. Vratonjic (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Renal filtration function and early complications after elective coronary artery bypass grafting
Professor O. Yepanchintseva (Kiev, UA)
Abstract Slides Video
Presentation thumbnail
Ischemic heart disease attributable to high body mass index in pakistan versus worldwide: an analysis of the global burden of disease study 2021
Assistant Professor B. Akinci (Istanbul, TR)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic coronary syndromes and comorbidities

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Age and risk scores for detecting coronary artery calcification in heterozygous familial hypercholesterolemia
thumbnail
Congress Presentation
Cardiovascular risk among individuals with and without genetic mutation for familial hypercholesterolemia: A long-term follow-up study
thumbnail
Congress Presentation
Symptomatic patients without coronary artery disease do not have excess cardiovascular risk compared to the general population

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources